Stock Price
251.40
Daily Change
-49.60 -16.48%
Monthly
-36.68%
Yearly
-60.67%
Q1 Forecast
285.47

Novo Nordisk reported DKK542.9B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Bausch Health Companies USD 26.37B 458M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pacira USD 1.3B 239.68M Sep/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Supernus Pharmaceuticals USD 1.42B 37.35M Sep/2025